PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oncology Department, Wuhan No.1 Hospital, Wuhan, 430022, China.\', \'Institute of Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilian-University Munich, Munich, Germany.\', \'Department of Orthopedics, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan, 430030, Province Hubei, China. godocoto@163.com.\', \'Department of Orthopedics, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan, 430030, Province Hubei, China.\', \'Institute of Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-82810-3
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33846344
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all